• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[激肽释放酶-激肽系统在原发性高血压发病机制中的意义]

[The significance of the kallikrein-kinin system in the pathogenesis of essential hypertension].

作者信息

Jiao K R, Zhang S M, Xu K C

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 1989 Apr;17(2):96-8, 127.

PMID:2551623
Abstract

The levels of plasma kininase II (ACE), a high molecular weight-kininogen (HMW), alpha 2-mega-globular protein (alpha 2M), prekallikrein (PK), alpha 1-antitrypsin (alpha 1 AT) were determined in essential hypertension and control groups. The results showed that there is significant increase of ACE and PK activity and HMW content in patients with essential hypertension than in control group (P less than 0.001). No changes in alpha 2M and alpha 1AT were found. These results suggest that human plasma kallikrein system was inhibited in patients with essential hypertension.

摘要

在原发性高血压组和对照组中测定了血浆激肽释放酶II(血管紧张素转换酶,ACE)、高分子量激肽原(HMW)、α2-巨球蛋白(α2M)、前激肽释放酶(PK)、α1-抗胰蛋白酶(α1AT)的水平。结果显示,原发性高血压患者的ACE和PK活性以及HMW含量比对照组显著升高(P<0.001)。未发现α2M和α1AT有变化。这些结果提示,原发性高血压患者的人血浆激肽释放酶系统受到抑制。

相似文献

1
[The significance of the kallikrein-kinin system in the pathogenesis of essential hypertension].[激肽释放酶-激肽系统在原发性高血压发病机制中的意义]
Zhonghua Xin Xue Guan Bing Za Zhi. 1989 Apr;17(2):96-8, 127.
2
Increased activity of plasma and tissue kallikreins, plasma kininase II and salivary kallikrein in pemphigus foliaceus (fogo selvagem).落叶型天疱疮(巴西落叶型天疱疮)患者血浆和组织激肽释放酶、血浆激肽酶II及唾液激肽释放酶活性增加。
Br J Dermatol. 2005 Apr;152(4):650-7. doi: 10.1111/j.1365-2133.2005.06427.x.
3
Studies of the plasma kinin-forming system in cirrhosis of the liver.
Acta Hepatogastroenterol (Stuttg). 1975 Apr;22(2):89-92.
4
[State of the kallikrein-kinin system in blood from the heart ventricle in the dynamics of spontaneous hypertension in the rat].[大鼠自发性高血压动态过程中心室血液中激肽释放酶-激肽系统的状态]
Vopr Med Khim. 1984 Sep-Oct;30(5):110-3.
5
[Seasonal fluctuations in the kallikrein-kinin system indices].[激肽释放酶-激肽系统指标的季节性波动]
Vopr Med Khim. 1979 May-Jun;25(3):266-8.
6
Determination of kininogens levels and kallikrein/kininase II activities in patients with thromboangiitis obliterans.血栓闭塞性脉管炎患者激肽原水平及激肽释放酶/激肽酶II活性的测定
Scand J Immunol. 2010 Aug;72(2):128-33. doi: 10.1111/j.1365-3083.2010.02408.x.
7
[Effect of thymalin on the function of the blood kallikrein-kinin system in thymectomized rats].
Biull Eksp Biol Med. 1985 Jun;99(6):654-6.
8
[Kallikrein-kinin systems of the blood in hypertension].
Klin Med (Mosk). 1984 Jan;62(1):49-53.
9
Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.对正常个体和脓毒性休克患者血浆样本中血浆激肽释放酶-激肽系统成分的研究。
Adv Shock Res. 1980;4:1-10.
10
Kallikrein-kinin system in diabetic patients.
Arzneimittelforschung. 1988 May;38(5):721-3.